Market Overview

NTRR Narrows Focus to Five Key Areas in Nutraceutical Market

Share:
SARASOTA, Fla.--(BUSINESS WIRE)--

Neutra Corp. (OTCBB: NTRR), an emerging nutritional supplement provider, announced today that it will focus its new product development efforts on all-natural medicines designed to remedy five key wellness issues: weight-loss, sexual potency, energy, sleeplessness and detoxification.

“These market segments are the main drivers behind nutraceutical sales revenues surpassing $151 billion dollars, and the demand continues to grow,” said NTRR CEO Cindy Morrissey. “People have been turning to prescription drugs to lose weight, energize themselves, enjoy better sex, fall asleep faster and cleanse their systems for decades, suffering through drug side effects for results. These are some of the most common and treatable health issues afflicting consumers today. NTRR is working to turn traditional, organic solutions to these problems into all-natural medicines with no side effects that are just as potent and effective as their pharmaceutical counterparts.”

Due to increasingly busy lifestyles including bad food, less free time and rising stress, people around the world are looking for answers to their most common health concerns. Increasingly, consumers are turning their backs on pharmaceuticals in favor of nutraceuticals—all-natural remedies derived from nutrients, botanicals, herbs and minerals. Analysts predict that the nutraceuticals market will grow to at least $207.3 billion by 2016. By focusing on its most profitable segments, NTRR plans to carve out an early position in a rapidly growing sector.

“The demand for weight-loss products is proven,” Morrissey said. “The demand for sleeping pills is proven. Each of these five sectors is a proven and lucrative consumer market that is growing by the day. We aim to generate big profits by producing innovative new solutions with none of the drawbacks of synthetic drugs.”

Neutra Corp. is working to acquire proven, effective formulas to compete in the rising nutraceuticals industry alongside Vitacost.com, Inc. (NASDAQ: VITC), GNC Holdings, Inc. (NYSE: GNC), Vitamin Shoppe, Inc. (NYSE: VSI), and BioScrip, Inc. (NASDAQ: BIOS).

For more information on NTRR's nutraceuticals initiative, please visit www.neutracorp.com/investors.

Follow NTRR on Twitter at www.twitter.com/neutracorp.

About Neutra Corp.

Neutra Corp. (www.neutracorp.com) is a healthy lifestyle company that specializes in all-natural medicine formulas engineered to prevent and treat specific medical conditions. Free from the side effects caused be synthetic pharmaceuticals, Nuetra Corp. nutraceuticals are intended to work as effectively, if not moreso, than prescribed drugs. For investing information and performance data, please visit www.neutracorp.com/investors.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.

Neutra Corp.
Cindy Morrissey, 713-821-1486
President and CEO
info@neutracorp.com

View Comments and Join the Discussion!